The incidence of young-onset rectal cancer is increasing, and emerging evidence suggests younger patients have more aggressive disease. The standard of care for stage II and III rectal cancer includes neoadjuvant chemoradiotherapy followed by surgery and adjuvant chemotherapy. The purpose of this study was to determine whether response to neoadjuvant chemoradiotherapy differs in young-onset rectal cancer patients compared to older individuals
Recent literature suggests that the benefit of adjuvant chemotherapy (aCT) for rectal cancer patient...
Many older patients don't receive appropriate oncological treatment. Our aim was to analyse whether ...
Aims: The aim of this study was to define a potential benefit of pathological complete response rate...
The incidence of young-onset rectal cancer is increasing, and emerging evidence suggests younger pat...
To address the difference of pathologic and clinical characteristics of the young and the middle-age...
Background: Young-onset rectal cancer, in patients less than 50 years, is expected to increase in th...
Background: Optimal treatment for locally advanced rectal cancer is neoadjuvant (chemo)radiation fol...
Purpose This study analyzed the current approaches for rectal cancer treatment in elderly patients. ...
Background This study sought to examine the use of radical treatment for rectal cancer (neoadjuvant ...
Background: The number of cases of rectal cancer in our older cohort is expected to rise with our ag...
Background: Rectal cancer (RC) among young patients (50 years) Demographic, comorbidities, procedure...
The elderly population comprises a significant proportion of patients diagnosed with rectal cancer. ...
Background: The number of cases of rectal cancer in our older cohort is expected to rise with our ag...
THE AIM of the study was to evaluate time-to-progression (TTP) of rectal cancer in a group of patien...
Background: Young patients with rectal cancer tend to present with more advanced-stage disease and u...
Recent literature suggests that the benefit of adjuvant chemotherapy (aCT) for rectal cancer patient...
Many older patients don't receive appropriate oncological treatment. Our aim was to analyse whether ...
Aims: The aim of this study was to define a potential benefit of pathological complete response rate...
The incidence of young-onset rectal cancer is increasing, and emerging evidence suggests younger pat...
To address the difference of pathologic and clinical characteristics of the young and the middle-age...
Background: Young-onset rectal cancer, in patients less than 50 years, is expected to increase in th...
Background: Optimal treatment for locally advanced rectal cancer is neoadjuvant (chemo)radiation fol...
Purpose This study analyzed the current approaches for rectal cancer treatment in elderly patients. ...
Background This study sought to examine the use of radical treatment for rectal cancer (neoadjuvant ...
Background: The number of cases of rectal cancer in our older cohort is expected to rise with our ag...
Background: Rectal cancer (RC) among young patients (50 years) Demographic, comorbidities, procedure...
The elderly population comprises a significant proportion of patients diagnosed with rectal cancer. ...
Background: The number of cases of rectal cancer in our older cohort is expected to rise with our ag...
THE AIM of the study was to evaluate time-to-progression (TTP) of rectal cancer in a group of patien...
Background: Young patients with rectal cancer tend to present with more advanced-stage disease and u...
Recent literature suggests that the benefit of adjuvant chemotherapy (aCT) for rectal cancer patient...
Many older patients don't receive appropriate oncological treatment. Our aim was to analyse whether ...
Aims: The aim of this study was to define a potential benefit of pathological complete response rate...